Yeo MJR, Zhang O, Xie X, et al. UM171 glues asymmetric CRL3-HDAC1/2 assembly to degrade CoREST corepressors. Nature. 2025. doi:10.1038/s41586-024-08532-4
Chemical Biology and Therapeutics Science Program
Waterbury AL, Caroli J, Zhang O, et al. Covalent adduct Grob fragmentation underlies LSD1 demethylase-specific inhibitor mechanism of action and resistance. Nature communications. 2025;16(1):3156. doi:10.1038/s41467-025-57477-3
Xie X, Zhang O, Yeo MJR, et al. Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations. Nature. 2025. doi:10.1038/s41586-024-08533-3
Zhang J, Ali MY, Chong HB, et al. Oxidation of retromer complex controls mitochondrial translation. Nature. 2025. doi:10.1038/s41586-025-08756-y
Pergu R, Vedagopuram S, Kokkonda P, et al. Phosphorylation-inducing molecules for regulating dynamic cellular processes. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.05.10.652895
Khirallah J, Bloomer H, Wich D, et al. base editing of Angptl3 via lipid nanoparticles to treat cardiovascular disease. Molecular therapy. Nucleic acids. 2025;36(2):102486. doi:10.1016/j.omtn.2025.102486
Musunuru K, Grandinette S, Wang X, et al. Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease. The New England journal of medicine. 2025. doi:10.1056/NEJMoa2504747
Tachida Y, Manian K V, Butcher R, et al. Systematic empirical evaluation of individual base editing targets: validating therapeutic targets in USH2A and comparison of methods. Molecular therapy : the journal of the American Society of Gene Therapy. 2025. doi:10.1016/j.ymthe.2025.01.042
Waterbury AL, Iram I, Liau BB. Building the first base editors. Nature chemical biology. 2025;21(1):16-17. doi:10.1038/s41589-024-01790-3
Matuszek Żaneta, Arbab M, Kesavan M, et al. Base editing of trinucleotide repeats that cause Huntington’s disease and Friedreich’s ataxia reduces somatic repeat expansions in patient cells and in mice. Nature genetics. 2025. doi:10.1038/s41588-025-02172-8